Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
The purpose of the study is to determine patient characteristics from patients that have used Iressa for a period of minimal 3 years.
Inclusion Criteria: